Questions? Call us today! 760-437-5318

Jitakshi De, President & CEO MD, MLS

Jitakshi De, M.D., M.L.S. President & CEO has over 10 years of experience in pathology, with the main focus on hematologic disorders. She has previously served as a Laboratory Director and as a Director of Hematopathology for high complexity testing. Dr. De is an expert in blood and bone marrow pathology and flow cytometry analyses and interpretations. She is uniquely talented in applying novel technologies, including single-cell gene and protein expression analyses as new diagnostic assays in the clinic.

Dr. De is a Physician Scientist / Pathologist and Entrepreneur, Founder, President, and Chief Executive Officer of Deepath Diagnostics, Inc. She holds a Bachelor’s in Biology with Highest Honors from UNC – Chapel Hill, and earned her M.D. from Duke University School of Medicine. Dr. De completed her residency in Anatomic and Clinical Pathology from University of Texas at Houston (2003 – 2007) and a fellowship in Hematopathology from University of Michigan Health System (2008 – 2009). She has a Masters in Legal Studies in Healthcare Law (M.L.S., 08/2017 – 12/2018) online from University of Oklahoma. She brings valuable industry experience in cytometry technologies, high dimensional data analysis, and cell-based disease biomarkers, with a particular focus on hematologic and oncologic disorders. Her research spans from genotypic-phenotypic correlations to stem cell biology and detection of leukemic stem/progenitor cells, and applications of high dimensional single cell analysis technologies.

Paul H. Kane, Lead Algorithm Engineer B. Tech

Paul Kane has an extensive background in signal processing and analysis of biomedical data acquired by sophisticated technologies, including magnetic resonance spectroscopy and mass spectrometry. His expertise is in continuous problem solving through the application of advanced techniques combining signal and data processing, image analysis, and analytical mechanics. He applies intuition and a solid background in engineering and physics fundamentals for pattern classification of high dimensional cytometry data.

Christian T. Ballentine Director, Operations

CT is a sound engineer and a recording artist who brings his creative insights into the operations while supporting cloud-based cytometry data analytics and social media-based marketing.


Eli Ansari is the Investment Advisor to DeePath.

Serial entrepreneur and operator with extensive experience in the technology industry (Big Data, SaaS, and Artificial Intelligence) as an operator, investment banker and venture capitalist. As a Managing Director at Boustead Securities (FINRA member & SEC Registered Broker Dealer), Eli assists enterprises with M&A, capital raising and strategy to further enterprise’s initiatives and expedite time to market. Eli is an expert in originating and managing transactions from inception to completion, including crafting compelling investment theses and assembling marketing materials to convey these financial narratives, identifying investors (buyers), managing the due diligence process and negotiating the transactions, while addressing FINRA/SEC regulatory reporting.

Manoj Kenkare is a Strategic Advisor to Deepath.

Over 20 years of experience in healthcare and life sciences consulting. Manoj is also very active in the Silicon Valley Venture Capital community. During his career, Manoj has worked on several transformation deals with Fortune 100 and some key institutions like The Whitehouse, FDA, NIH and CDC. Manoj was instrumental in advising few of the startups, such as AthenaHealth and CipherTrace, among others. Manoj has been interviewed for and appeared for the Science Magazine, Drug Discovery Online, MDDI (Medical Device & Diagnostics), TheStreet, WSJ, RedHerring, China TV, and MSNBC. Key areas of focus have been Digitization of R&D org, Product development, Data Analytics, AI, RPA, ERP applications, Analytics, Mobility, Workday, Cloud, and Portal strategy, among others.

Ramani Aiyer is a Scientific and Clinical Advisor to Deepath.

Chief Business Officer offers strategic advisory and business development consultancy services to Life Science companies. He has >20 years of experience in the biopharmaceutical and clinical diagnostics industries, with major roles in R&D strategic planning, while mentoring scientists and leading diverse project teams. He holds a PhD in Biochemistry from Harvard, and has post-doctoral research experience from Stanford and Dana Farber Cancer Institute. He received his MBA from the University of California, Berkeley Haas School of Management. Earlier, he was the Chief Scientific Officer at Actis Biologics, and prior to that, Senior VP, R&D Strategic Planning at Piramal Life Sciences. His other roles include senior-level positions at Genentech, TransMed Biotech, LifeScan (acquired by Johnson & Johnson), and Sugen (acquired by Pharmacia/Pfizer).

To be announced, Chief Technology Officer